相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Central line-associated bloodstream infections caused by Staphylococcus aureus in cancer patients: Clinical outcome and management
Aline El Zakhem et al.
ANNALS OF MEDICINE (2014)
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
E. Tacconelli et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Risk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer
Kyungmin Huh et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
The current spectrum of infection in cancer patients with chemotherapy related neutropenia
Lior Nesher et al.
INFECTION (2014)
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients
Marta Bodro et al.
SUPPORTIVE CARE IN CANCER (2014)
Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients
Yuriko Fukuta et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2013)
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome
Si-Hyun Kim et al.
ANNALS OF HEMATOLOGY (2013)
Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients
C. Gudiol et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System
M. E. A. de Kraker et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance
E. Montassier et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)
Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013
C Glasner et al.
Eurosurveillance (2013)
The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients
Inge C. Gyssens et al.
HAEMATOLOGICA (2013)
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia
Diana Averbuch et al.
HAEMATOLOGICA (2013)
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies
Michael J. Satlin et al.
LEUKEMIA & LYMPHOMA (2013)
Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity
Yong Chong et al.
PLOS ONE (2013)
Increase in Bloodstream Infection Due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes
Carlota Gudiol et al.
PLOS ONE (2013)
A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies
George Samonis et al.
SUPPORTIVE CARE IN CANCER (2013)
Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit
A. Cumpston et al.
TRANSPLANT INFECTIOUS DISEASE (2013)
Stormy waters ahead: global emergence of carbapenemases
Gopi Patel et al.
FRONTIERS IN MICROBIOLOGY (2013)
Risk factors for infection and treatment outcome of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy
Cheol-In Kang et al.
ANNALS OF HEMATOLOGY (2012)
P. aeruginosa bloodstream infections among hematological patients: an old or new question?
Chiara Cattaneo et al.
ANNALS OF HEMATOLOGY (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Infusional β-lactam antibiotics in febrile neutropenia: has the time come?
Iain J. Abbott et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2012)
Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010)
Ana C. Gales et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Clinical impact of cycling the administration of antibiotics for febrile neutropenia in Japanese patients with hematological malignancy
S. Hashino et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2012)
Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study
Christian Kjellander et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
The rise of the Enterococcus: beyond vancomycin resistance
Cesar A. Arias et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Patients with Cancer Treated with Vancomycin: 9-Year Experience at a Comprehensive Cancer Center
Sminil N. Mahajan et al.
ONCOLOGIST (2012)
Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies
Patricia Cornejo-Juarez et al.
PLOS ONE (2012)
Antimicrobial Stewardship in Patients with Cancer
Frank P. Tverdek et al.
PHARMACOTHERAPY (2012)
Tracking a Hospital Outbreak of Carbapenem-Resistant Klebsiella pneumoniae with Whole-Genome Sequencing
Evan S. Snitkin et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia
Cheol-In Kang et al.
SUPPORTIVE CARE IN CANCER (2012)
In Vitro Interactions of Antimicrobial Combinations with Fosfomycin against KPC-2-Producing Klebsiella pneumoniae and Protection of Resistance Development
Maria Souli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: emerging resistance
Dylan R. Pillai et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
G. L. Daikos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients
Eric James Bow
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies
Enrico Maria Trecarichi et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with hematological malignancies
Yong Chong et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)
Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes
C. Gudiol et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of beta-lactams
Joao Goncalves-Pereira et al.
CRITICAL CARE (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant Pseudomonas aeruginosa Infections in Immunocompromised Patients
Brad Moriyama et al.
ANNALS OF PHARMACOTHERAPY (2010)
The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Mini Kamboj et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Perils of Quinolone Exposure in Cancer Patients Breakthrough Bacteremia With Multidrug-Resistant Organisms
Gopi Rangaraj et al.
CANCER (2010)
Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia
C. -Y. Chen et al.
EPIDEMIOLOGY AND INFECTION (2010)
Multidrug resistant Pseudomonas aeruginosa infection in children undergoing chemotherapy and hematopoietic stem cell transplantation
Desiree Caselli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept
Jason A. Roberts et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Health Care-Associated Invasive MRSA Infections, 2005-2008
Alexander J. Kallen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
Carlota Gudiol et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
Elizabeth B. Hirsch et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Prospective Observational Study of the Impact of VIM-1 Metallo-β-Lactamase on the Outcome of Patients with Klebsiella pneumoniae Bloodstream Infections
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Factors associated with bacteremia due to multidrug-resistant Gram-negative bacilli in hematopoietic stem cell transplant recipients
M. Garnica et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2009)
A systematic review on clinical benefits of continuous administration of β-lactam antibiotics
Jason A. Roberts et al.
CRITICAL CARE MEDICINE (2009)
Transition of Enterococcus faecium from commensal organism to nosocomial pathogen
Rob J. L. Willems et al.
FUTURE MICROBIOLOGY (2009)
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA
Andrea Endimiani et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Acinetobacter: an old friend, but a new enemy
K. J. Towner
JOURNAL OF HOSPITAL INFECTION (2009)
Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
Enrico M. Trecarichi et al.
JOURNAL OF INFECTION (2009)
Tigecycline Use in Cancer Patients With Serious Infections A Report on 110 Cases From a Single Institution
Roy F. Chemaly et al.
MEDICINE (2009)
Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients
L. E. Johnson et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Isolation of imipenem-resistant Enterobacter species:: Emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes
Dror Marchaim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study
Seema Irfan et al.
BMC INFECTIOUS DISEASES (2008)
Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies
Gopi Patel et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE
Louis B. Rice
JOURNAL OF INFECTIOUS DISEASES (2008)
Emergence of clonal complex 17 Enterococcus faecium in the Netherlands
Janetta Top et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Stenotrophomonas maltophilia:: Changing spectrum of a serious bacterial pathogen in patients with cancer
Amar Safdar et al.
CLINICAL INFECTIOUS DISEASES (2007)
Bacteraernia in febrile neutropenic cancer patients
J. Klastersky et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy:: patients with acute myeloid leukemia are at high-risk
Leon J. Worth et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium Bacteremia in cancer patients
G. Ghanem et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Bloodstream infections in febrile neutropenic patients at a tertiary care center in Lebanonon: a view of the past decade
Zeina A. Kanafani et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Risk factors for infections with multidrug-resistant Stenotrophomonas maltophilia in patients with cancer
Shoaib R. Ansari et al.
CANCER (2007)
Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients
Debra D. Poutsiaka et al.
JOURNAL OF INFECTION (2007)
Epidemiology of bacteremia and factors associated with multi-drug-resistant gram-negative bacteremia in hematopoietic stem cell transplant recipients
A. L. Oliveira et al.
BONE MARROW TRANSPLANTATION (2007)
Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant
David M. Weinstock et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit
M. Craig et al.
BONE MARROW TRANSPLANTATION (2007)
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Anton Y. Peleg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?
E. R. Dubberke et al.
BONE MARROW TRANSPLANTATION (2006)
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with Hematologic malignancies
E. J. Bow et al.
CLINICAL INFECTIOUS DISEASES (2006)
Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia
MH Scheetz et al.
PHARMACOTHERAPY (2006)
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer
B Jaksic et al.
CLINICAL INFECTIOUS DISEASES (2006)
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients
A Glasmacher et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Ceftazidime in acute myeloid leukemia patients with febrile neutropenia: Helpfulness of continuous intravenous infusion in maximizing pharmacodynamic exposure
F Pea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003:: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents
PR Hsueh et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection
CA DiazGranados et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens
R Ramphal
CLINICAL INFECTIOUS DISEASES (2004)
Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
PA Moise-Broder et al.
CLINICAL INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Current spectrum of bacterial infections in patients with cancer
D Yadegarynia et al.
CLINICAL INFECTIOUS DISEASES (2003)
Comparative activity and spectrum of broad-spectrum β-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci:: report from the SENTRY antimicrobial surveillance program (North America:: 2001-2002)
TR Fritsche et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2003)
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2003)
Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia
PF Smith et al.
ANNALS OF ONCOLOGY (2003)
Epidemiology and risk factors for gram-positive coccal infections in neutropenia: Toward a more targeted antibiotic strategy
C Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2003)
Health and economic outcomes of vancomycin-resistant enterococci
Y Carmeli et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Effectiveness of a multifaceted infection control policy in reducing vancomycin usage and vancomycin-resistant enterococci at a tertiary care cancer centre
ZHA Shaikh et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Of Pseudomonas, porins, pumps and carbapenems
DM Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Predisposing factors and outcome of Staphylococcus aureus bacteremia in neutropenic patients with cancer
E González-Barca et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2001)
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
D Pittet et al.
LANCET (2000)
Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation
D Kapur et al.
BONE MARROW TRANSPLANTATION (2000)
A pilot study of antibiotic cycling in a hematology-oncology unit
EA Dominguez et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2000)
分享论文
